TJ, et al. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion [J]. Thorax,1994, 49(11):11521156.
[3]李玉皓，王新允，张乃鑫，等. 非小细胞肺癌DNA含量和细胞凋亡相关性研究 [J]. 中国肿瘤临床, 2000,27(18):578580.
[4]Pina TC, Zapata IT, Lopez JB, et al. DNA aneuploidy, Sphase fraction and nuclear p53 positivity in nonsmall cell lung carcinoma [J]. Clin Biochem,1999,32(5):347354.
[5]左连富. 流式细胞术与生物医学 [M]. 沈阳:辽宁科学技术出版社,1996:214219.
[6]Tinnemans MM, Lenders MH, ten Velde GP, et al. Prognostic value of cytokinetic parameters in lung cancer in vivo bromodeoxyuridine labelling [J]. Anticancer Res,1999,19(1A):531534.
[7]师恩炜，江晓菁，李玉，等. 原发性肺癌DNA含量的检测及意义 [J]. 中国医科大学学报, 2001, 30(1):4143.
[8]Choma D, Daures JP, Quantin X, et al. Aneuploidy and prognosis of NSCLC: a metaanalysis of published data [J]. Br J Cancer, 2001,85(1):1422.
[9]Hofmann HS, Knolle J, Bahn H, et al. Flow cytometric analysis of DNA content and proliferation and immunohistochemical staining of Ki67 in nonsmall cell lung cancer [J]. J Cardiovasc Surg, 2001,42(4):555560.
上一页 [1] [2] [3] [4]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文